Key result
PDA stenting raises oxygen saturation by ~20 percentage points in duct-dependent pulmonary blood flow.
Why the study?
This study aimed to evaluate the efficacy and safety of transcatheter patent ductus arteriosus stenting in neonates with ductal dependent pulmonary blood flow.
Does transcatheter patent ductus arteriosus (PDA) stenting safely and effectively improve oxygen saturation and provide palliation in neonates with ductal dependent pulmonary blood flow?
Cohort (n=40)
No
Does transcatheter patent ductus arteriosus (PDA) stenting safely and effectively improve oxygen saturation and provide palliation in neonates with ductal dependent pulmonary blood flow?
Answers are grounded in this paper and cite their sources.
Transcatheter PDA stenting is an effective and safe primary palliative intervention that significantly improves oxygen saturation in neonates with ductal-dependent pulmonary blood flow, though younger age and elongated or atypical PDA morphology increase the risk of re-intervention.
Aim: To evaluate the efficacy and safety of transcatheter patent ductus arteriosus (PDA) stenting in neonates with ductal dependent pulmonary blood flow (DD-PBF). Methods: This retrospective cohort study was performed in patients with DD-PBF and PDA stenting from July 2020 to March 2023. Demographics, prior treatments, diagnoses, PDA-related information, intervention (stenting) data, and outcomes were recorded. Re-interventions and mortality data were also assessed. Results: The median age of the patients was 8 (1 - 100) days; 25 were females and 15 were males. Oxygen saturation increased significantly after index PDA stenting (p<0.001). Complication rate was 15%. Complications included ventricular fibrillation in one patient, complete AV block in one patient, short-term SVT in one patient, stent embolization in one patient, pseudoaneurysm in one patient, and floppy wire stuck in one patient. During follow-up, no patient died due to stent-related complications. Median length of intensive care unit stay was 8 days after the procedures. Re-intervention was required in 6 (15.00%) patients during follow-up. Median re-intervention time was 95 (48 - 232) days. Surgical repair was performed in 24 patients at a median of 83 (12-344) days. Stent placement at younger age, atypical PDA type and elongated PDA were associated with higher likelihood of re-intervention. Conclusion: PDA stenting is an efficient and safe primary palliative intervention with manageable complication rates among children reliant on DD-PBF. There appears to be higher risks for re-intervention among younger children and those with elongated or atypical PDAs.
No takes yet. Share an insight, caveat, or question.
Yakut et al. (2025) conducted a cohort in Ductal dependent pulmonary blood flow (DD-PBF) (n=40). Transcatheter patent ductus arteriosus (PDA) stenting vs. Pre-intervention baseline was evaluated on Oxygen saturation (%) (p=<0.001).
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: